Role of insulin-like growth factor I signaling in neurodegenerative diseases.
about
Exercise-induced cognitive plasticity, implications for mild cognitive impairment and Alzheimer's diseaseInsulin in central nervous system: more than just a peripheral hormoneUpregulation of the E3 ligase NEDD4-1 by oxidative stress degrades IGF-1 receptor protein in neurodegenerationSignificantly Higher Peripheral Insulin-Like Growth Factor-1 Levels in Patients With Major Depressive Disorder or Bipolar Disorder Than in Healthy Controls: A Meta-Analysis and Review Under Guideline of PRISMAGIGYF2 gene disruption in mice results in neurodegeneration and altered insulin-like growth factor signalingEffect of sericin on diabetic hippocampal growth hormone/insulin-like growth factor 1 axisMelatonin anticancer effects: reviewPeripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model.Insulin-Like Growth Factor 1 (IGF-1) in Parkinson's Disease: Potential as Trait-, Progression- and Prediction Marker and Confounding Factors.Native and Complexed IGF-1: Biodistribution and Pharmacokinetics in Infantile Neuronal Ceroid Lipofuscinosis.FoxG1 promotes the survival of postmitotic neurons.Intraparenchymal spinal cord delivery of adeno-associated virus IGF-1 is protective in the SOD1G93A model of ALSInsulin-like growth factor-1 and delirium in critically ill mechanically ventilated patients: a preliminary investigation.Neurogenesis in the aging brainSerum insulin-like growth factor-1 and nitric oxide levels in Parkinson's disease.Autophagy resolves early retinal inflammation in Igf1-deficient miceBeta-amyloid toxicity and reversal in embryonic rat septal neurons.IGF-IR in neuroprotection and brain tumors.Mechanisms mediating brain plasticity: IGF1 and adult hippocampal neurogenesis.Beta-amyloid toxicity in embryonic rat astrocytes.Integrating insulin-like growth factor 1 and sex hormones into neuroprotection: Implications for diabetes.Neurobiological aspects of Alzheimer's disease.Beta-amyloid monomer and insulin/IGF-1 signaling in Alzheimer's disease.Integrative neurobiology of metabolic diseases, neuroinflammation, and neurodegeneration.SIRT1 silencing confers neuroprotection through IGF-1 pathway activation.Amyloid-β transmission or unexamined bias?Neuronal death by oxidative stress involves activation of FOXO3 through a two-arm pathway that activates stress kinases and attenuates insulin-like growth factor I signaling.The GH-IGF system in amyotrophic lateral sclerosis: correlations between pituitary GH secretion capacity, insulin-like growth factors and clinical features.Altered Insulin/Insulin-Like Growth Factor Signaling in a Comorbid Rat model of Ischemia and β-Amyloid Toxicity.
P2860
Q21129438-A2BC85BD-56EE-4A13-AF71-E5A9D91AD7B2Q21296648-E58CD1F2-B4B2-43AA-BA37-EA16A316D33BQ24613053-6D66A847-7CE2-4376-8EF4-73DF8A946F83Q26772966-28D5656D-E7E9-452A-B695-326059F0FDEFQ28593816-A74B4FA0-D1A8-48AA-AB09-496CB2C935ABQ34094720-5CAC02AE-CF0F-4433-BBD5-CD1B0CA2B930Q34647628-64120315-CC7A-48E5-ACFD-B4621E0163CBQ35327028-B9EACD7E-EA91-4380-8F75-25FCB7AA9C59Q35953962-389620A5-F869-4752-8DA6-3119D6FF7DCAQ36063386-058FA022-E570-47A7-8F85-3F8F3A6238E3Q36267774-32F47ABE-4469-4B48-9A49-769321D5EE73Q36491424-229DB3DA-21B1-483C-9BBB-FAA8B63EF8F5Q36845604-4B85844A-CC87-4360-8B6A-FA97BA0938EAQ37069038-A20333C9-84A5-48D1-B3AE-F3267F86489BQ37127609-72335EF0-381A-40EA-B162-729C1EA1EFB2Q37305891-AF23048D-B1AD-436A-8F96-F3D788811D3AQ37362146-1FC2916B-0F72-483F-BAAD-4E6E2DABBA85Q37409955-97025776-FC5D-49EA-9713-1D8B57496C22Q37421064-CA0821EF-26A0-427E-850D-78D38818D99CQ37592514-69CB7344-1C2B-4CD8-A721-116AF096C84AQ37658425-07F814EC-2380-4B51-A9A1-6A320E331525Q37840095-E35B4068-738C-4FB5-81A5-C2E24A9EA754Q38034089-E069B997-A964-4F9D-BBF2-E2748FB4BC7CQ38515285-197746D6-1705-4892-9961-7BC55F65FF1EQ39202722-F9D816CA-E6EA-4E80-B658-F2006D4D0783Q40581348-4372A58A-A873-4919-BA0C-6EF2C8C13EC7Q43205399-899CD75F-A101-4C21-945A-DC8E1D4155D9Q43225312-70A73FC4-831B-4BFC-8DE8-65FFD754A79EQ55024132-1E06F882-FEF5-4AE7-829B-BF2D7B165C1D
P2860
Role of insulin-like growth factor I signaling in neurodegenerative diseases.
description
2003 nî lūn-bûn
@nan
2003 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Role of insulin-like growth factor I signaling in neurodegenerative diseases.
@ast
Role of insulin-like growth factor I signaling in neurodegenerative diseases.
@en
Role of insulin-like growth factor I signaling in neurodegenerative diseases.
@nl
type
label
Role of insulin-like growth factor I signaling in neurodegenerative diseases.
@ast
Role of insulin-like growth factor I signaling in neurodegenerative diseases.
@en
Role of insulin-like growth factor I signaling in neurodegenerative diseases.
@nl
prefLabel
Role of insulin-like growth factor I signaling in neurodegenerative diseases.
@ast
Role of insulin-like growth factor I signaling in neurodegenerative diseases.
@en
Role of insulin-like growth factor I signaling in neurodegenerative diseases.
@nl
P1476
Role of insulin-like growth factor I signaling in neurodegenerative diseases
@en
P2093
Eva Garcia-Galloway
José Luis Trejo
P2888
P304
P356
10.1007/S00109-003-0499-7
P577
2003-11-28T00:00:00Z
P5875
P6179
1029505898